Form 8-K - Current report:
SEC Accession No. 0001193125-21-206346
Filing Date
2021-07-01
Accepted
2021-07-01 16:31:19
Documents
12
Period of Report
2021-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d138443d8k.htm   iXBRL 8-K 21467
  Complete submission text file 0001193125-21-206346.txt   139336

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sgmo-20210628.xsd EX-101.SCH 2887
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmo-20210628_lab.xml EX-101.LAB 17372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmo-20210628_pre.xml EX-101.PRE 10949
5 EXTRACTED XBRL INSTANCE DOCUMENT d138443d8k_htm.xml XML 3282
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 211066280
SIC: 2836 Biological Products, (No Diagnostic Substances)